ticlopidine has been researched along with Muscular Weakness in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SG | 1 |
| Shim, KS | 1 |
| Lee, DW | 1 |
| Kim, EJ | 1 |
| Lee, SG | 1 |
| Lee, JH | 1 |
| An, JH | 1 |
| Vera, M | 1 |
| Pou, M | 1 |
| Botey, A | 1 |
| Cases, A | 1 |
2 other studies available for ticlopidine and Muscular Weakness
| Article | Year |
|---|---|
Intramuscular hematoma with motor weakness after trigger point injection: A case report.
Topics: Aged; Biopsy, Fine-Needle; Buttocks; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; F | 2017 |
[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
Topics: Anticholesteremic Agents; Anuria; Clopidogrel; Coronary Artery Bypass; Humans; Hypercholesterolemia; | 2001 |